Manabu Akazawa, Ph.D.
Affiliations: | 2007 | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Public HealthGoogle:
"Manabu Akazawa"Cross-listing: PHTree
Parents
Sign in to add mentorAndrea K. Biddle | grad student | 2007 | UNC Chapel Hill | |
(Economic evaluation of treating chronic obstructive pulmonary disease: The effects of early initiation of inhaled corticosteroids on exacerbation risks, utilization and costs.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Blanchette CM, Broder M, Ory C, et al. (2009) Cost and utilization of COPD and asthma among insured adults in the US. Current Medical Research and Opinion. 25: 1385-92 |
Blanchette CM, Akazawa M, Dalal A, et al. (2008) Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults. The American Journal of Geriatric Pharmacotherapy. 6: 138-46 |
Akazawa M, Halpern R, Riedel AA, et al. (2008) Economic burden prior to COPD diagnosis: a matched case-control study in the United States. Respiratory Medicine. 102: 1744-52 |
Akazawa M, Stearns SC, Biddle AK. (2008) Assessing treatment effects of inhaled corticosteroids on medical expenses and exacerbations among COPD patients: longitudinal analysis of managed care claims. Health Services Research. 43: 2164-82 |
Akazawa M, Biddle AK, Stearns SC. (2008) Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching. Clinical Therapeutics. 30: 1003-16 |
Akazawa M, Hayflinger DC, Stanford RH, et al. (2008) Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease. The American Journal of Managed Care. 14: 438-48 |
Blanchette CM, Gutierrez B, Ory C, et al. (2008) Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population. Journal of Managed Care Pharmacy : Jmcp. 14: 176-85 |
Rascati KL, Akazawa M, Johnsrud M, et al. (2007) Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen. Clinical Therapeutics. 29: 1203-13 |
Akazawa M, Stearns S, Biddle A. (2007) PRS8 ASSESSING TREATMENT EFFECTS OF INHALED CORTICOSTEROID ON MEDICAL COSTS AMONG COPD PATIENTS: LONGITUDINAL ANALYSIS OF MANAGED CARE CLAIMS Value in Health. 10: A179 |
Rascati K, Akazawa M, Johnsrud M, et al. (2007) PRS7 COMPARISON OF EVENTS (HOSPITALIZATIONS AND EMERGENCY DEPARTMENT VISITS) AND COSTS FOR MEDICAID PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) BY INITIAL MEDICATION REGIMEN Value in Health. 10: A179 |